Tien Chi/Garlic & American Ginseng

by Root To Health · other (e.g. tea bag) · 100 mg

  • Off the market since November 2023 (NIH)
  • UPC 0 53181 01960 6
  • DSLD label 2991
  • Serving 1 caplet

Tien Chi/Garlic & American Ginseng by Root To Health lists 3 ingredients, 3 with an amount per serving of 1 caplet, such as 300 mg of american ginseng, 300 mg of garlic and 50 mg of tien chi. Its current label entered the NIH Dietary Supplement Label Database on December 23, 2011.

What is in Tien Chi/Garlic & American Ginseng?

Each row as the label prints it, per serving of 1 caplet. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Tien Chi/Garlic & American Ginseng: Supplement Facts rows against the market (DSLD label 2991, January 2026 release)
IngredientAmount% DVAmong products listing it
American Ginseng300 mgAmerican Ginseng in Tien Chi/Garlic & American Ginseng against 235 products300 mg per serving; the middle half of products list 75 mg to 425 mg, the median 200 mg.300 mg

Higher than 67% of 235 products listing american ginseng (median 200 mg). Per day at the most servings: 900 mg.

garlicgarlic Note: Allicin potential 2500mcg/dose300 mgGarlic in Tien Chi/Garlic & American Ginseng against 1,075 products300 mg per serving; the middle half of products list 50 mg to 500 mg, the median 200 mg.300 mg

Higher than 59% of 1,075 products listing garlic (median 200 mg). Per day at the most servings: 900 mg.

Tien Chi50 mg

Source: NIH ODS Dietary Supplement Label Database, label 2991 (entered December 23, 2011), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 3 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Tien Chi/Garlic & American Ginseng's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: 1 caplet 3 times daily.

Source: label statements in DSLD label 2991.

What else is on the label?

Other ingredients: Microcystallline cellulose, Dibasic Calcium Phosphate, Croscarmellose Sodium, Cellulose Acetate Phthalate, Stearic Acid, Silicon Dioxide, Colloidal, Magnesium Stearate, Diethyl Phthalate.

How many labels does Tien Chi/Garlic & American Ginseng have?

One label is on file, entered on December 23, 2011.

  1. Label 2991 (current) Entered December 23, 2011 · off the market November 17, 2023 · 100 mg · UPC 0 53181 01960 6

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Hsu's Ginseng Enterprises, Inc. (manufacturer), Wausau, WI. All Root To Health products.

Where next?